References

1. Andras, S.C.; Power, J.B.; Cocking, E.C.; Davey, M.R. Strategies for signal amplification in nucleic acid detection. Mol. Biotechnol. 2001, 19, 29-44.

2. Lisby, G. Application of nucleic acid amplification in clinical microbiology. Mol. Biotechnol. 1999, 12, 75-99.

3. Nolte, F.S. Branched DNA signal amplification for direct quantitation of nucleic acid sequences in clinical specimens. Adv. Clin. Chem. 1998, 33, 201-235.

4. Ross, R.S.; Viazov, S.; Sarr, S.; Hoffmann, S.; Kramer, A.; Roggendorf, M. Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay. J. Virol. Methods 2002, 101, 159-168.

5. Bushnell, S.; Budde, J.; Catino, T.; Cole, J.; Derti, A.; Kelso, R.; Collins, M.L.; Molino, G.; Sheridan, P.; Monahan, J.; Urdea, M. ProbeDesigner: For the design of probesets for branched DNA (bDNA) signal amplification. Bioinformatics 1999, 15, 348-355.

6. Berger, A.; Preiser, W.; Doerr, H.W. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J. Clin. Virol. 2001, 20, 23-30.

7. Yao, J.D.C.; Beld, M.G.H.M.; Oon, L.L.E.; Sherlock, C.H.; Germer, J.; Menting, S.; Thoe, S.Y.S.; Merrick, L.; Ziermann, R.; Surtihadi, J.; Hnatyszyn, H.J. Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay. J. Clin. Microbiol. 2004, 42, 800- 806.

8. Saldanha, J.; Gerlich, W.; Lelie, N.; Dawson, P.; Heermann, K.; Heath, A.; The WHO Collaborative Study Group. An international collaborative study to establish a World Health Organisation international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang. 2001, 80, 63-71.

9. Pawlotsky, J.-M. Molecular diagnosis of viral hepatitis. Gastroenterology 2002, 122, 1554-1568.

10. Gilbert, N.; Corder, S.; Ijaz, S.; Grant, P.R.; Tedder, R.S.; Boxall, E.H. Comparison of commercial assays for the quantification of HBV DNA load in health care workers: Calibration differences. J. Virol. Methods 2002, 100, 3747.

11. Beld, M.; Sentjens, R.; Rebers, S.; Weegink, C.; Weel, J.; Sol, C.; Boom, R. Performance of the new Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C RNA in plasma and serum: Conversion to international units and comparison with Roche COBAS Amplicor HCV Monitor, version 2.0, assay. J. Clin. Microbiol. 2002, 40, 788-793.

12. Trimoulet, P.; Halfon, P.; Pohier, E.; Khiri, H.; Chene, G.; Fleury, H. Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum. J. Clin. Microbiol. 2002, 40, 2031-2036.

13. Saldanha, J.; Lelie, N.; Heath, A.; WHO Collaborative Study Group. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Vox Sang. 1999, 76, 149158.

14. Pawlotsky, J.-M.; Bouvier-Alias, M.; Hezode, C.; Dar-thuy, F.; Remire, J.; Dhumeaux, D. Standardization of hepatitis C virus RNA quantification. Hepatology 2000, 32, 654-659.

15. Germer, J.J.; Heimgartner, P.J.; Ilstrup, D.M.; Harmsen, W.S.; Jenkins, G.D.; Patel, R. Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS Amplicor HCV Monitor 2.0 assays for quantification of hepatitis C virus RNA in serum. J. Clin. Microbiol. 2002, 40, 495-500.

16. Gleaver, C.A.; Welle, J.; Campbell, M.; Elbeik, T.; Ng, V.; Taylor, P.E.; Kuramoto, K.; Aceituno, S.; Lewalski, E.; Joppa, B.; Sawywe, L.; Schaper, C.; McNairn, D.; Quinn, T. Multicenter evaluation of Bayer VERSANTâ„¢ HIV-1 RNA 3.0 assay: Analytical and clinical performance. J. Clin. Virol. 2001, 25, 205-216.

17. Bayer Corporation. VERSANT HIV-1 RNA 3.0 Assay (bDNA). Product Sheet; Bayer Corporation Tarrytown, NY, 2002.

18. Holmes, H.; Davis, C.; Heath, A.; Hewlett, I.; Lelie, N. An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid techniques. J. Virol. Methods 2001, 92, 141-150.

19. Department of Health and Human Services (DHHS). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents; November 10, 2003. http://aidsinfo.nih.gov/guidelines/adult/AA_111003.html (accessed February 18, 2004).

20. Iqbal, S.S.; Chambers, J.P.; Brubaker, R.R.; Goode, M.T.; Valdes, J.J. Detection of Yersinia pestis using branched DNA. Mol. Cell. Probes 1999, 13, 315-320.

21. Fluit, A.C.; Visser, M.R.; Schmitz, F.-J. Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev. 2001, 14, 836-871.

22. Genospectra. QuantiGeneâ„¢ Products. http:/www. genospectra.com/prod_QP.html (accessed February 18, 2004).

23. Qian, X.; Lloyd, R.V. Recent developments in signal amplification for in situ hybridisation. Diagn. Mol. Pathol. 2003, 12, 1-13.

24. Kenny, D.; Shen, L.-P.; Kolberg, J.A. Detection of viral infection and gene expression in clinical tissue specimens using branched DNA (bDNA) in situ hybridisation. J. Histochem. Cytochem. 2002, 50, 1219-1227.

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook


Post a comment